Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Rtw Biotech (RTW) Share Price

Intraday
Historical

Price	$1.94 on 20-03-2026 at 18:10:08
Change	$-0.02 -1.02%
Buy	$1.96
Sell	$1.945

Last Trade:	Buy 4,632.00 at $1.94
Day's Volume:	1,493,573
Last Close:	$1.94
Open:	$1.93
ISIN:	GG00BKTRRM22

Day's Range	$1.93 - $1.995
52wk Range:	$1.08 - $2.32
Market Capitalisation:	$632.97m
VWAP:	$1.945216
Shares in Issue:	326.27m

Buy/Sell	Volume	Trade Prc	Trade Type	Trade Time
Rtw Biotech (RTW) Latest Trades
Buy*	4,632	$1.94	SI Trade Negotiated Trade	16:48:31 - 20-Mar-26
Buy*	339	$1.94984	SI Trade Negotiated Trade	16:47:08 - 20-Mar-26
Buy*	30,966	$1.94	SI Trade	16:36:33 - 20-Mar-26
Sell*	225,686	$1.94	Automatic Execution	16:35:28 - 20-Mar-26
Sell*	694,463	$1.94	Uncrossing Trade	16:35:25 - 20-Mar-26
Buy*	3	$1.96	SI Trade	16:29:58 - 20-Mar-26
Sell*	78	$1.95	Automatic Execution	16:10:32 - 20-Mar-26
Sell*	5,530	$1.95	Automatic Execution	16:10:32 - 20-Mar-26
Sell*	3,371	$1.95	Automatic Execution	15:53:00 - 20-Mar-26
Sell*	5,141	$1.95	Automatic Execution	15:53:00 - 20-Mar-26

See more Rtw Biotech trades

Rtw Biotech (RTW) Share Price History
Time period: to
Date	Open	High	Low	Close	Volume
20th Mar 2026 (Fri)	1.93	1.995	1.93	1.94	1,493,573
19th Mar 2026 (Thu)	1.905	1.96	1.87	1.96	974,489
18th Mar 2026 (Wed)	1.96	1.98	1.91	1.915	1,308,948
17th Mar 2026 (Tue)	1.93	1.98	1.93	1.955	529,890
16th Mar 2026 (Mon)	2.01	2.02	1.93	1.94	421,028
13th Mar 2026 (Fri)	1.985	2.05	1.97	1.99	485,750
12th Mar 2026 (Thu)	2.06	2.09	1.98	1.98	784,288
11th Mar 2026 (Wed)	2.06	2.10	2.05	2.06	544,979
10th Mar 2026 (Tue)	2.00	2.09	1.985	2.09	425,398
9th Mar 2026 (Mon)	1.945	2.01	1.91	1.99	416,534
6th Mar 2026 (Fri)	2.02	2.02	1.945	1.965	363,409
5th Mar 2026 (Thu)	2.01	2.03	1.99	1.99	79,732
4th Mar 2026 (Wed)	1.99	2.02	1.98	2.00	1,208,361
3rd Mar 2026 (Tue)	2.04	2.04	1.97	1.99	354,898
2nd Mar 2026 (Mon)	2.07	2.09	2.05	2.06	228,362
27th Feb 2026 (Fri)	2.10	2.10	2.07	2.09	215,396
26th Feb 2026 (Thu)	2.10	2.11	2.07	2.07	68,235
25th Feb 2026 (Wed)	2.09	2.13	2.09	2.10	101,437
24th Feb 2026 (Tue)	2.10	2.11	2.08	2.09	276,109
23rd Feb 2026 (Mon)	2.09	2.11	2.08	2.10	488,235
20th Feb 2026 (Fri)	2.10	2.10	2.07	2.10	352,286

See more Rtw Biotech price history

Date	Source	Headline
Rtw Biotech (RTW) Regulatory News
19th Mar 2026 7:00 am	RNS	Transaction in Own Shares
18th Mar 2026 7:00 am	RNS	Transaction in Own Shares
17th Mar 2026 7:00 am	RNS	Transaction in Own Shares
17th Mar 2026 7:00 am	RNS	Transaction in Own Shares
16th Mar 2026 7:01 am	RNS	Transaction in Own Shares
16th Mar 2026 7:01 am	RNS	Transaction in Own Shares
16th Mar 2026 7:00 am	RNS	Notice of 2025 Annual Results & Webinar
16th Mar 2026 7:00 am	RNS	Notice of 2025 Annual Results & Webinar
13th Mar 2026 7:01 am	RNS	Transaction in Own Shares
13th Mar 2026 7:01 am	RNS	Transaction in Own Shares

See more Rtw Biotech regulatory news

Rtw Biotech (RTW) Share News

IN BRIEF: RTW Biotech's largest private investment completes financing

23rd Jan 2026 11:23

RTW Biotech Opportunities Ltd - Guernsey-based investor in the life sciences sector - Corxel Pharmaceuticals Ltd, RTW's largest private investment, has completed Series D-1 financing worth USD287 million. Says Corxel is a clinical-stage biopharmaceutical company developing therapies for cardiometabolic conditions, and its lead candidate, CX11, is an oral GLP-1 receptor agonist for obese and overweight patients currently in a phase 2 US trial. Expects the financing proceeds to support the advancement of this trial, as well as a planned global phase 2 trial in type 2 diabetes mellitus and initial preparations for phase 3 studies and other cardiometabolic programmes. Read More

IN BRIEF: RTW Biotech welcomes GSK deal to buy RAPT Therapeutics

21st Jan 2026 11:37

RTW Biotech Opportunities Ltd - Guernsey-based investor in the life sciences sector - Notes GSK PLC's announcement on Tuesday that it has agreed to acquire RAPT Therapeutics Inc. Says RAPT, a Californian biopharmaceutical company developing therapies for inflammatory and immunologic diseases, represented 0.15% of its net asset value as of December 31. The all-cash transaction values RAPT at USD2.2 billion, with shareholders to receive USD58 per share. RTW says the price represents a 65% premium to RAPT's closing price on Monday. Read More

See more Rtw Biotech news

FTSE 100 Latest

Value9,918.33

Change-145.17

Rtw Biotech (RTW) Share Price

Login to your account